✦ LIBER ✦

9008 Clinical outcomes of bevacizumab in combination with paclitaxel/carboplatin compared with paclitaxel/carboplatin alone in previously untreated Japanese patients with advanced non-squamous non-small-cell lung cancer (NSCLC)

✍ Scribed by Ichinose, Y.; Seto, T.; Kunitoh, H.; Horai, T.; Nishiwaki, Y.; Hida, T.; Yamamoto, N.; Kawahara, M.; Saijo, N.; Fukuoka, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of first-line

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

A phase II study of weekly paclitaxel an

✍ Andre Michel Kallab; Yasolatha Nalamolu; Paul Maclyn Dainer; Anand Prasad Jillel 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 73 KB

Randomised phase II study of ASA404 comb

✍ McKeage, M J; Von Pawel, J; Reck, M; Jameson, M B; Rosenthal, M A; Sullivan, R; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 174 KB

Figitumumab combined with carboplatin an

✍ Yasushi Goto, Ikuo Sekine, Maki Tanioka, Takashi Shibata, Chiharu Tanai, Hajime 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 282 KB

9141 Volociximab (V) in combination with

✍ Besse, B.; Soria, J.C.; Chico, I.; Tsao, C.; Ding, H.; Belani, C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Bevacizumab, when Added to Paclitaxel/Ca

✍ Preeta Tyagi; Chandra P. Belani 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 447 KB